Literature DB >> 6978986

Computerized tomography of the temporal bone.

G E Valvassori, M F Mafee, G D Dobben.   

Abstract

Computerized tomography is acquiring an increasingly important role in the radiographic assessment of the temporal bone. In the latest generation of CT scanners, spacial resolution has been reduced to 0.1 cu mm and slice thickness to 1.5 mm. The main advantages of computerized tomography in comparison to multidirectional tomography are the improved contrast of the images and above all the clear demonstration of soft tissue structures and masses within or adjacent to the temporal bone. The following three applications of computerized tomography will be discussed: 1. Evaluation of intratemporal soft tissue masses. Computerized tomography allows differentiation of fluid filled from solid masses and vascular tumors. 2. Assessment of lesions extending outside the temporal bone or into the temporal bone from adjacent structures. In these cases CT will demonstrate the temporal bone involvement and the presence and extension of the intra or extra cranial component of the lesion. 3. Study of the cerebellopontine angle. Computerized tomography with infusion and combined with pneumocisternography comprise the procedure of choice for the diagnosis of acoustic neuromas and other lesions occurring in this area.

Entities:  

Mesh:

Year:  1982        PMID: 6978986     DOI: 10.1288/00005537-198205000-00018

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  2 in total

1.  High resolution O2 computed meatocisternography in the differential diagnosis of internal auditory canal pathology.

Authors:  P Bassi; C Zini; F Cusmano; M Sanna
Journal:  Neuroradiology       Date:  1985       Impact factor: 2.804

Review 2.  Updates and knowledge gaps in cholesteatoma research.

Authors:  Chin-Lung Kuo; An-Suey Shiao; Matthew Yung; Masafumi Sakagami; Holger Sudhoff; Chih-Hung Wang; Chyong-Hsin Hsu; Chiang-Feng Lien
Journal:  Biomed Res Int       Date:  2015-03-18       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.